FDAnews
www.fdanews.com/articles/134628-neoprobe-shares-soar-on-lymphoseek-clinical-trial-results

Neoprobe Shares Soar on Lymphoseek Clinical Trial Results

February 25, 2011
Shares of Neoprobe continue their strong performance of recent weeks, rising by as much as 8 percent in early Friday trading after the company published results from a phase II clinical trial of its cancer-targeting agent.
Med City News